DuckWiseArchive › BMY
BMY trade ideas: every closed DuckWise idea on Bristol-Myers Squibb Company
DuckWise has published 2 ideas on Bristol-Myers Squibb Company (BMY, Stock) that have closed between December 2020 and February 2022. Each is listed below with the levels published before the position was taken and its result at close — 2 in profit, 0 at a loss.
| Opened | Closed | Side | Entry | Stop | Projection | Close | Result | Days |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2021 | Feb 25, 2022 | Long | 60.92 | — | 75 | 69.50 | +14.08% | 157 |
| Dec 15, 2020 | Jul 28, 2021 | Long | 60.93 | — | 80 | 69.30 | +13.74% | 225 |
Prices in US dollars. Result is the price change from the published entry to the published close, before fees, taxes and slippage. How results are counted.
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Pays a dividend yield of 4.12% annually.
These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell BMY or any other security.